miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.
Xiaoting LiuJinhu ChenTianyuan GuanHui YaoWenpei ZhangZhenlong GuanYanqin WangPublished in: BMC systems biology (2019)
This study provides data of potential biomarkers and therapeutic targets for PD diagnosis and treatment. Among them, hsa-miR-142 is a critical miRNA in the PD network, and may be involved in PD progression by regulating GNAQ, TMTC2, BEND2, and KYNU.